• Casella Family Brands wine label [yellow tail] has launched its latest drop for the summer, adding Mediterranean Lemon Spritz to its popular Sparkling Cocktails range.
Source: [yellow tail]
    Casella Family Brands wine label [yellow tail] has launched its latest drop for the summer, adding Mediterranean Lemon Spritz to its popular Sparkling Cocktails range. Source: [yellow tail]
Close×

Casella Family Brands wine label [yellow tail] has launched its latest drop for the summer, adding Mediterranean Lemon Spritz to its popular Sparkling Cocktails range.

The new ready-to-drink craft cocktail joins the lineup of [yellow tail] Sparkling Cocktail innovations that launched in November last year, which includes Wild Peach Bellini and Blood Orange Mimosa.

Spritz cocktails are continuing to surge in popularity, with the category seeing a +40.4 per cent volume growth and +34.5 per cent value growth in the wine segment.

To cater to this trend, Mediterranean Lemon Spritz delivers a refreshing taste of summer with its vibrant citrus flavors, blending all-natural lemon with Australian sparkling wine. The cocktail’s balanced acidity and subtle bitterness create a refined complexity for any occasion.

[yellow tail] brand manager, Madeleine Legoe, said Mediterranean Lemon spritz is the perfect zesty new addition to our Sparkling cocktails range.

“With the growth of lemon and RTDs, there was an opportunity to innovate recruiting younger consumers into the category and [yellow tail] brand,” said Legoe.

“Available just in time for Summer, it’s the perfect ready to drink cocktail, with no preparation necessary.”

The new Mediterranean Lemon Spritz Sparkling Cocktail ABV 10.5% is available exclusively at Dan Murphy's for RRP $18.

Packaging News

Pact Group will delist from the ASX on Wednesday 16 July, the move being the culmination of executive chair and owner Raphael Geminder’s near two-year bid to take full control of the company.

Packaging is at the heart of Suntory’s bold new chapter in Australia, marked by the opening of its $400 million beverage production facility in Swanbank, Queensland – a site purpose-built to deliver high-speed, high-efficiency bottling, canning and kegging through world-class packaging technology and sustainable design.

Ego Pharmaceuticals has unveiled a bold new chapter in its commitment to local manufacturing, announcing a $156 million, decade-long investment to expand its Victorian operations.